A few studies have evaluated higher doses or the administration or a loading dose, which is routine in adults, in pediatric patients, and reported improved colistin exposure without an increased risk of nephrotoxicity The main questions it aims to answer are What is the optimal dosing strategies of intravenous colistin for the treatment of multidrug-resistant gram-negative bacterial infections in preterm neonates? What is the incidence of AKI? What is the factors increasing AKI incidence? A single center retrospective and comparative study, cohort study compare low dose 5 mg/kg/day versus 7.5mg/kg/day
Retrospective study to measure safety and efficacy of colistin conventional dose versus high dose then prospective design to measure pharmacokinetics parameter of both doses to design optimal dose
Study Type
OBSERVATIONAL
Enrollment
100
Increased starting colistin dose
Cairo univrsity Hospitals
Cairo, Egypt
RECRUITINGClinical response
Resolving signs and symptoms with normalized acute phase reactants in clinical septic patients
Time frame: 21 days
Microbiological clearance
Negative culture results following Colistin therapy
Time frame: 21 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.